Eli Lilly (LLY) stock rallied on Thursday after the pharmaceutical company posted its Q3 2025 earnings report. This report started with adjusted earnings per share of $7.02, which was well above Wall Street’s estimate of $5.69. It also represented a 494.9% increase year-over-year from $1.18 per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Revenue reported by Eli Lilly came in at $17.6 billion, which was another beat compared to analysts’ estimate of $16.05 billion. It also climbed 54% year-over-year compared to $11.44 billion.